Login Register Cart 0
Generic placeholder image

Nanoscience & Nanotechnology-Asia

Editor-in-Chief

ISSN (Print): 2210-6812
ISSN (Online): 2210-6820

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

The Remarkable Role of Nano-phytocosmeceuticals for Elevating Skincare in Facial Hyperpigmentation

Author(s): Tanya Mathur, Neha Jain*, Unnati Garg and Manisha Pandey*

Volume 14, Issue 3, 2024

Published on: 20 June, 2024

Article ID: e200624231108 Pages: 17

DOI: 10.2174/0122106812299476240604104440

Price: $65

Abstract

The common skin disorder known as facial hyperpigmentation is caused by an uneven distribution of melanin, which leaves the face with dark areas or spots. Numerous factors, such as inflammation, hormonal fluctuations, and sun exposure, might contribute to this condition. Chemical peels, laser therapy, and topical whitening agents are examples of traditional treatments for facial hyperpigmentation. On the other hand, these treatments may cause scarring, dryness, and inflammation of the skin. For the treatment of facial hyperpigmentation, nano-phytocosmeceuticals— cosmeceuticals containing nanoparticles generated from plant extracts—have shown great promise. Compared to traditional cosmeceuticals, these innovative formulations provide several benefits, such as better skin penetration, increased active ingredient bioavailability, and fewer side effects. Additionally, they have proved to be useful in lowering melanin synthesis and lightening hyperpigmented skin. Thus, an overview of the recent advances in the development and application of nanophytocosmeceuticals for facial hyperpigmentation, along with clinical studies and patents that have been granted have been provided in this article.

Graphical Abstract

[1]
Syder, N.C.; Quarshie, C.; Elbuluk, N. Disorders of facial hyperpigmentation. Dermatol. Clin., 2023, 41(3), 393-405.
[http://dx.doi.org/10.1016/j.det.2023.02.005] [PMID: 37236709]
[2]
Moolla, S.; Miller-Monthrope, Y. Dermatology: How to manage facial hyperpigmentation in skin of colour. Drugs Context, 2022, 11, 1-14.
[http://dx.doi.org/10.7573/dic.2021-11-2] [PMID: 35720052]
[3]
Nautiyal, A.; Wairkar, S. Management of hyperpigmentation: Current treatments and emerging therapies. Pigment Cell Melanoma Res., 2021, 34(6), 1000-1014.
[http://dx.doi.org/10.1111/pcmr.12986] [PMID: 33998768]
[4]
Doolan, B.J.; Gupta, M. Melasma. Aust. J. Gen. Pract., 2021, 50(12), 880-885.
[http://dx.doi.org/10.31128/AJGP-05-21-6002] [PMID: 34845463]
[5]
Kwon, S.H.; Na, J.I.; Choi, J.Y.; Park, K.C. Melasma: Updates and perspectives. Exp. Dermatol., 2019, 28(6), 704-708.
[http://dx.doi.org/10.1111/exd.13844] [PMID: 30422338]
[6]
Morgado-Carrasco, D.; Piquero-Casals, J.; Granger, C.; Trullàs, C.; Passeron, T. Melasma: The need for tailored photoprotection to improve clinical outcomes. Photodermatol. Photoimmunol. Photomed., 2022, 38(6), 515-521.
[http://dx.doi.org/10.1111/phpp.12783] [PMID: 35229368]
[7]
Markiewicz, E.; Karaman-Jurukovska, N.; Mammone, T.; Idowu, O.C. Post-inflammatory hyperpigmentation in dark skin: Molecular mechanism and skincare implications. Clin. Cosmet. Investig. Dermatol., 2022, 15, 2555-2565.
[http://dx.doi.org/10.2147/CCID.S385162] [PMID: 36466945]
[8]
Scarcella, G.; Dethlefsen, M.W.; Nielsen, M.C.E. Treatment of solar lentigines using a combination of picosecond laser and biophotonic treatment. Clin. Case Rep., 2018, 6(9), 1868-1870.
[http://dx.doi.org/10.1002/ccr3.1749] [PMID: 30214780]
[9]
Oh, S.M.; Lee, Y.E.; Ko, M.J.; Baek, J.H.; Shin, M.K. Proposal of facial pigmentary unit and facial hyperpigmentation type for Fitzpatrick skin types II-IV. Skin Res. Technol., 2023, 29(1), e13251.
[http://dx.doi.org/10.1111/srt.13251] [PMID: 36478452]
[10]
Wawrzyńczak, A. Cosmetic and pharmaceutic products with selected natural and synthetic substances for melasma treatment and methods of their analysis. Cosmetics, 2023, 10(3), 86.
[http://dx.doi.org/10.3390/cosmetics10030086]
[11]
Hanif, N.; Al-Shami, A.M.A.; Khalid, K.A.; Hadi, H.A. Plant-based skin lightening agents: A review. Journal of Phytopharmacology, 2020, 9(1), 54-60.
[http://dx.doi.org/10.31254/phyto.2020.9109]
[12]
Goelzer Neto, C.F.; do Nascimento, P.; da Silveira, V.C.; de Mattos, A.B.N.; Bertol, C.D. Natural sources of melanogenic inhibitors: A systematic review. Int. J. Cosmet. Sci., 2022, 44(2), 143-153.
[http://dx.doi.org/10.1111/ics.12763] [PMID: 35048395]
[13]
Morganti, P.; Coltelli, M.B. A new carrier for advanced cosmeceuticals. Cosmetics, 2019, 6(1), 10.
[http://dx.doi.org/10.3390/cosmetics6010010]
[14]
Ganesan, P.; Choi, D.K. Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy. Int. J. Nanomedicine, 2016, 11, 1987-2007.
[http://dx.doi.org/10.2147/IJN.S104701] [PMID: 27274231]
[15]
Souto, E.B.; Fernandes, A.R.; Martins-Gomes, C.; Coutinho, T.E.; Durazzo, A.; Lucarini, M.; Souto, S.B.; Silva, A.M.; Santini, A. Nanomaterials for skin delivery of cosmeceuticals and pharmaceuticals. Appl. Sci., 2020, 10(5), 1594.
[http://dx.doi.org/10.3390/app10051594]
[16]
Pandey, A.S.; Bawiskar, D.; Wagh, V. Nanocosmetics and skin health: A comprehensive review of nanomaterials in cosmetic formulations. Cureus, 2024, 16(1), e52754.
[http://dx.doi.org/10.7759/cureus.52754] [PMID: 38389646]
[17]
Singh, V.; Bansal, K.; Bhati, H.; Bajpai, M. New insights into pharmaceutical nanocrystals for the improved topical delivery of therapeutics in various skin disorders. Curr. Pharm. Biotechnol., 2023, 25.
[http://dx.doi.org/10.2174/0113892010276223231027075527] [PMID: 37921127]
[18]
Pingale, P.L.; Patil, R.A.; Bedse, A.P.; Raut, S.S. Natural nanoparticulate cosmeceuticals: Boon for hyperpigmentation. Curr. Tradit. Med., 2023, 10, 1-13.
[http://dx.doi.org/10.2174/0122150838266844230927052225]
[19]
Raina, N.; Rani, R.; Thakur, V.K.; Gupta, M. New insights in topical drug delivery for skin disorders: From a nanotechnological perspective. ACS Omega, 2023, 8(22), 19145-19167.
[http://dx.doi.org/10.1021/acsomega.2c08016] [PMID: 37305231]
[20]
Yoshioka, Y.; Kuroda, E.; Hirai, T.; Tsutsumi, Y.; Ishii, K.J. Allergic responses induced by the immunomodulatory effects of nanomaterials upon skin exposure. Front. Immunol., 2017, 8, 169.
[http://dx.doi.org/10.3389/fimmu.2017.00169] [PMID: 28261221]
[21]
Palumbo, A.; d’Ischia, M.; Misuraca, G.; Prota, G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim. Biophys. Acta, Gen. Subj., 1991, 1073(1), 85-90.
[http://dx.doi.org/10.1016/0304-4165(91)90186-K] [PMID: 1899343]
[22]
Jimbow, K.; Obata, H.; Pathak, M.A.; Fitzpatrick, T.B. Mechanism of depigmentation by hydroquinone. J. Invest. Dermatol., 1974, 62(4), 436-449.
[http://dx.doi.org/10.1111/1523-1747.ep12701679] [PMID: 4206837]
[23]
Boo, Y.C. Arbutin as a skin depigmenting agent with antimelanogenic and antioxidant properties. Antioxidants, 2021, 10(7), 1129.
[http://dx.doi.org/10.3390/antiox10071129] [PMID: 34356362]
[24]
Baliña, L.M.; Graupe, K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int. J. Dermatol., 1991, 30(12), 893-895.
[http://dx.doi.org/10.1111/j.1365-4362.1991.tb04362.x] [PMID: 1816137]
[25]
Chawla, S.; deLong, M.A.; Visscher, M.O.; Wickett, R.R.; Manga, P.; Boissy, R.E. Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives. Br. J. Dermatol., 2008, 159(6), 1267-1274.
[http://dx.doi.org/10.1111/j.1365-2133.2008.08864.x] [PMID: 18811684]
[26]
Piamphongsant, T. Treatment of melasma: A review with personal experience. Int. J. Dermatol., 1998, 37(12), 897-903.
[http://dx.doi.org/10.1046/j.1365-4362.1998.00585.x] [PMID: 9888328]
[27]
Ditre, CM; Griffin, TD; Murphy, GF; Sueki, H; Telegan, B; Johnson, WC Effects of alpha-hydroxy acids on photoaged skin: A pilot clinical, histologic, and ultrastructural study. J. Am. Acad. Dermatol., 1996, 34(2 Pt 1), 187-195.
[28]
Usuki, A.; Ohashi, A.; Sato, H.; Ochiai, Y.; Ichihashi, M.; Funasaka, Y. The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells. Exp. Dermatol., 2003, 12(s2)(Suppl. 2), 43-50.
[http://dx.doi.org/10.1034/j.1600-0625.12.s2.7.x] [PMID: 14756523]
[29]
Fischer, T.C.; Perosino, E.; Poli, F.; Viera, M.S.; Dreno, B. Chemical peels in aesthetic dermatology: An update 2009. J. Eur. Acad. Dermatol. Venereol., 2010, 24(3), 281-292.
[http://dx.doi.org/10.1111/j.1468-3083.2009.03409.x] [PMID: 19744174]
[30]
Rossi, A.M.; Perez, M.I. Treatment of hyperpigmentation. Facial Plast. Surg. Clin. North Am., 2011, 19(2), 313-324.
[http://dx.doi.org/10.1016/j.fsc.2011.05.010] [PMID: 21763992]
[31]
Guevara, I.L.; Pandya, A.G. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma. Int. J. Dermatol., 2003, 42(12), 966-972.
[http://dx.doi.org/10.1111/j.1365-4632.2003.02017.x] [PMID: 14636195]
[32]
Kim, Y.J.; Uyama, H. Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future. Cell. Mol. Life Sci., 2005, 62(15), 1707-1723.
[http://dx.doi.org/10.1007/s00018-005-5054-y] [PMID: 15968468]
[33]
Gust, P.J.; Luke, J.D. Kojic Acid. J. Dermatol. Nurses Assoc., 2016, 8(5), 338-340.
[http://dx.doi.org/10.1097/JDN.0000000000000247]
[34]
Nawarak, J.; Huang-Liu, R.; Kao, S.H.; Liao, H.H.; Sinchaikul, S.; Chen, S.T.; Cheng, S.L. Proteomics analysis of kojic acid treated A375 human malignant melanoma cells. J. Proteome Res., 2008, 7(9), 3737-3746.
[http://dx.doi.org/10.1021/pr7008737] [PMID: 18630942]
[35]
Nakagawa, M.; Kawai, K.; Kawai, K. Contact allergy to kojic acid in skin care products. Contact Dermat., 1995, 32(1), 9-13.
[http://dx.doi.org/10.1111/j.1600-0536.1995.tb00832.x] [PMID: 7720390]
[36]
Draelos, Z.D. Skin lightening preparations and the hydroquinone controversy. Dermatol. Ther., 2007, 20(5), 308-313.
[http://dx.doi.org/10.1111/j.1529-8019.2007.00144.x] [PMID: 18045355]
[37]
Ebanks, J.; Wickett, R.; Boissy, R. Mechanisms regulating skin pigmentation: The rise and fall of complexion coloration. Int. J. Mol. Sci., 2009, 10(9), 4066-4087.
[http://dx.doi.org/10.3390/ijms10094066] [PMID: 19865532]
[38]
Tangau, M.J.; Chong, Y.K.; Yeong, K.Y. Advances in cosmeceutical nanotechnology for hyperpigmentation treatment. J. Nanopart. Res., 2022, 24(8), 155.
[http://dx.doi.org/10.1007/s11051-022-05534-z]
[39]
Bergman, D.; Luke, J. Azelaic acid. J. Dermatol. Nurses Assoc., 2017, 9(3), 157-160.
[http://dx.doi.org/10.1097/JDN.0000000000000309]
[40]
Fitton, A.; Goa, K.L. Azelaic acid. Drugs, 1991, 41(5), 780-798.
[http://dx.doi.org/10.2165/00003495-199141050-00007] [PMID: 1712709]
[41]
Sheth, V.M.; Pandya, A.G. Melasma: A comprehensive update. J. Am. Acad. Dermatol., 2011, 65(4), 699-714.
[http://dx.doi.org/10.1016/j.jaad.2011.06.001] [PMID: 21920242]
[42]
Catani, M.V.; Rossi, A.; Costanzo, A.; Sabatini, S.; Levrero, M.; Melino, G.; Avigliano, L. Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. Biochem. J., 2001, 356(1), 77-85.
[http://dx.doi.org/10.1042/bj3560077] [PMID: 11336638]
[43]
Hakozaki, T.; Minwalla, L.; Zhuang, J.; Chhoa, M.; Matsubara, A.; Miyamoto, K.; Greatens, A.; Hillebrand, G.G.; Bissett, D.L.; Boissy, R.E. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br. J. Dermatol., 2002, 147(1), 20-31.
[http://dx.doi.org/10.1046/j.1365-2133.2002.04834.x] [PMID: 12100180]
[44]
Taraz, M.; Niknam, S.; Ehsani, A.H. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies. Dermatol. Ther. , 2017, 30(3), e12465.
[http://dx.doi.org/10.1111/dth.12465] [PMID: 28133910]
[45]
Cho, H.H.; Choi, M.; Cho, S.; Lee, J.H. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser. J. Dermatolog. Treat., 2013, 24(4), 292-296.
[http://dx.doi.org/10.3109/09546634.2011.643220] [PMID: 22103770]
[46]
Bala, H.R.; Lee, S.; Wong, C.; Pandya, A.G.; Rodrigues, M. Oral tranexamic acid for the treatment of melasma: A review. Dermatol. Surg., 2018, 44(6), 814-825.
[http://dx.doi.org/10.1097/DSS.0000000000001518] [PMID: 29677015]
[47]
Foley, H.M.; Steel, A.E. Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence. Complement. Ther. Med., 2019, 42, 65-81.
[http://dx.doi.org/10.1016/j.ctim.2018.11.003] [PMID: 30670284]
[48]
Besouw, M.; Masereeuw, R.; van den Heuvel, L.; Levtchenko, E. Cysteamine: An old drug with new potential. Drug Discov. Today, 2013, 18(15-16), 785-792.
[http://dx.doi.org/10.1016/j.drudis.2013.02.003] [PMID: 23416144]
[49]
Corden, B.J.; Schulman, J.D.; Schneider, J.A.; Thoene, J.G. Adverse reactions to oral cysteamine use in nephropathic cystinosis. Dev. Pharmacol. Ther., 1981, 3(1), 25-30.
[http://dx.doi.org/10.1159/000457418] [PMID: 7307866]
[50]
Sonthalia, S.; Daulatabad, D.; Sarkar, R. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies. Indian J. Dermatol. Venereol. Leprol., 2016, 82(3), 262-272.
[http://dx.doi.org/10.4103/0378-6323.179088] [PMID: 27088927]
[51]
Allen, J.; Bradley, R.D. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J. Altern. Complement. Med., 2011, 17(9), 827-833.
[http://dx.doi.org/10.1089/acm.2010.0716] [PMID: 21875351]
[52]
Pinto, J.M.N.; Delorenze, L.M.; Vasques, W.; Issa, M.C. Jessner’s Peel. Chemical and Physical Peelings; Springer International Publishing, 2016, pp. 1-6.
[http://dx.doi.org/10.1007/978-3-319-20252-5_4-1]
[53]
Mukherjee, S.; Date, A.; Patravale, V.; Korting, H.C.; Roeder, A.; Weindl, G. Retinoids in the treatment of skin aging: An overview of clinical efficacy and safety. Clin. Interv. Aging, 2006, 1(4), 327-348.
[http://dx.doi.org/10.2147/ciia.2006.1.4.327] [PMID: 18046911]
[54]
Wang, C.C.; Hui, C.Y.; Sue, Y.M.; Wong, W.R.; Hong, H.S. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol. Surg., 2004, 30(9), 1196-1200.
[http://dx.doi.org/10.1111/j.1524-4725.2004.30371.x] [PMID: 15355358]
[55]
Kawada, A.; Asai, M.; Kameyama, H.; Sangen, Y.; Aragane, Y.; Tezuka, T.; Iwakiri, K. Videomicroscopic and histopathological investigation of intense pulsed light therapy for solar lentigines. J. Dermatol. Sci., 2002, 29(2), 91-96.
[http://dx.doi.org/10.1016/S0923-1811(02)00014-2] [PMID: 12088609]
[56]
Xi, Z.; Gold, M.H.; Zhong, L.; Ying, L. Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma. Dermatol. Surg., 2011, 37(7), 962-970.
[http://dx.doi.org/10.1111/j.1524-4725.2011.02001.x] [PMID: 21615824]
[57]
Lee, M.W.C. Combination 532-nm and 1064-nm lasers for noninvasive skin rejuvenation and toning. Arch. Dermatol., 2003, 139(10), 1265-1276.
[http://dx.doi.org/10.1001/archderm.139.10.1265] [PMID: 14568830]
[58]
Passeron, T.; Fontas, E.; Kang, H.Y.; Bahadoran, P.; Lacour, J.P.; Ortonne, J.P. Melasma treatment with pulsed-dye laser and triple combination cream: A prospective, randomized, single-blind, split-face study. Arch. Dermatol., 2011, 147(9), 1106-1108.
[http://dx.doi.org/10.1001/archdermatol.2011.255] [PMID: 21931054]
[59]
Sarkar, R.; Arora, P.; Garg, V.; Arya, L. Lasers for treatment of melasma and post-inflammatory hyperpigmentation. J. Cutan. Aesthet. Surg., 2012, 5(2), 93-103.
[http://dx.doi.org/10.4103/0974-2077.99436] [PMID: 23060704]
[60]
Cichorek, M.; Wachulska, M.; Stasiewicz, A. Heterogeneity of neural crest-derived melanocytes. Open Life Sci., 2013, 8(4), 315-330.
[http://dx.doi.org/10.2478/s11535-013-0141-1]
[61]
Maghfour, J.; Olayinka, J.; Hamzavi, I.H.; Mohammad, T.F. A Focused review on the pathophysiology of post-inflammatory hyperpigmentation. Pigment Cell Melanoma Res., 2022, 35(3), 320-327.
[http://dx.doi.org/10.1111/pcmr.13038] [PMID: 35306737]
[62]
Liu, W.; Chen, Q.; Xia, Y. New mechanistic insights of melasma. Clin. Cosmet. Investig. Dermatol., 2023, 16, 429-442.
[http://dx.doi.org/10.2147/CCID.S396272] [PMID: 36817641]
[63]
Xu, H; Zheng, Y-W; Liu, Q; Liu, L-P; Luo, F-L; Zhou, H-C Reactive oxygen species in skin repair, regeneration, aging, and inflammation. In: Reactive Oxygen Species (ROS) in Living Cells; Intechopen 2018;
[http://dx.doi.org/10.5772/intechopen.72747]
[64]
Xing, X.; Dan, Y.; Xu, Z.; Xiang, L. Implications of oxidative stress in the pathogenesis and treatment of hyperpigmentation disorders. Oxid. Med. Cell. Longev., 2022, 2022, 1-12.
[http://dx.doi.org/10.1155/2022/7881717] [PMID: 35087618]
[65]
Khorsandi, K.; Hosseinzadeh, R.; Esfahani, H.; Zandsalimi, K.; Shahidi, F.K.; Abrahamse, H. Accelerating skin regeneration and wound healing by controlled ROS from photodynamic treatment. Inflamm. Regen., 2022, 42(1), 40.
[http://dx.doi.org/10.1186/s41232-022-00226-6] [PMID: 36192814]
[66]
Cerulli, A.; Masullo, M.; Montoro, P.; Piacente, S. Licorice (Glycyrrhiza glabra, G. uralensis, and G. inflata) and their constituents as active cosmeceutical ingredients. Cosmetics, 2022, 9(1), 7.
[http://dx.doi.org/10.3390/cosmetics9010007]
[67]
Huang, H.C.; Chang, T.Y.; Chang, L.Z.; Wang, H.F.; Yih, K.H.; Hsieh, W.Y.; Chang, T.M. Inhibition of melanogenesis versus antioxidant properties of essential oil extracted from leaves of Vitex negundo Linn and chemical composition analysis by GC-MS. Molecules, 2012, 17(4), 3902-3916.
[http://dx.doi.org/10.3390/molecules17043902] [PMID: 22466851]
[68]
Zheng, Y.; Lee, E.H.; Lee, S.Y.; Lee, Y.; Shin, K.O.; Park, K.; Kang, I.J. Morus alba L. root decreases melanin synthesis via sphingosine-1-phosphate signaling in B16F10 cells. J. Ethnopharmacol., 2023, 301, 115848.
[http://dx.doi.org/10.1016/j.jep.2022.115848] [PMID: 36272492]
[69]
Kim, K. Effect of ginseng and ginsenosides on melanogenesis and their mechanism of action. J. Ginseng Res., 2015, 39(1), 1-6.
[http://dx.doi.org/10.1016/j.jgr.2014.10.006] [PMID: 25535470]
[70]
Biernacka, P.; Adamska, I.; Felisiak, K. The potential of Ginkgo biloba as a source of biologically active compounds—a review of the recent literature and patents. Molecules, 2023, 28(10), 3993.
[http://dx.doi.org/10.3390/molecules28103993] [PMID: 37241734]
[71]
Moy, R.L.; Levenson, C. Sandalwood album oil as a botanical therapeutic in dermatology. J. Clin. Aesthet. Dermatol., 2017, 10(10), 34-39.
[PMID: 29344319]
[72]
Rathee, P.; Kumar, S.; Kumar, D.; Kumari, B.; Yadav, S.S. Skin hyperpigmentation and its treatment with herbs: An alternative method. Futur. J. Pharm. Sci., 2021, 7(1), 132.
[http://dx.doi.org/10.1186/s43094-021-00284-6]
[73]
Rahimi, V.B.; Askari, V.R.; Emami, S.A.; Tayarani-Najaran, Z. Anti-melanogenic activity of Viola odorata different extracts on B16F10 murine melanoma cells. Iran. J. Basic Med. Sci., 2017, 20(3), 242-249.
[http://dx.doi.org/10.22038/ijbms.2017.8350] [PMID: 28392894]
[74]
Kim, K.H.; Moon, E.; Kim, S.Y.; Lee, K.R. Lignans from the tuber-barks of Colocasia antiquorum var. esculenta and their antimelanogenic Activity. J. Agric. Food Chem., 2010, 58(8), 4779-4785.
[http://dx.doi.org/10.1021/jf100323q] [PMID: 20359228]
[75]
Ha, J.H.; Kang, W.H.; Lee, J.O.; Cho, Y.K.; Park, S.K.; Lee, S.K.; Cho, H.K. Clinical evaluation of the depigmenting effect of Glechoma Hederacea extract by topical treatment for 8 weeks on UV-induced pigmentation in Asian skin. Eur. J. Dermatol., 2011, 21(2), 218-222.
[http://dx.doi.org/10.1684/ejd.2010.1232] [PMID: 21411411]
[76]
What you should know about Alpha Arbutin as a skin brightening substance. Available from: https://sublimelife.in/blogs/sublime-stories/meet-alpha-arbutin-the-best-kept-secret-of-skin-brightening (accessed April 12, 2024).
[77]
Sugier, P.; Sęczyk, Ł.; Sugier, D.; Krawczyk, R.; Wójcik, M.; Czarnecka, J.; Okoń, S.; Plak, A. Chemical characteristics and antioxidant activity of Arctostaphylos uva-ursi L. Spreng. at the southern border of the geographical range of the species in europe. Molecules, 2021, 26(24), 7692.
[http://dx.doi.org/10.3390/molecules26247692] [PMID: 34946773]
[78]
Kang, M.H.; Jang, G.Y.; Ji, Y.J.; Lee, J.H.; Choi, S.J.; Hyun, T.K.; Kim, H.D. Antioxidant and anti-melanogenic activities of heat-treated licorice (Wongam, glycyrrhiza glabra × g. uralensis) extract. Curr. Issues Mol. Biol., 2021, 43(2), 1171-1187.
[http://dx.doi.org/10.3390/cimb43020083] [PMID: 34563052]
[79]
Randomized, A. A comparative study of the safety and efficacy of 75% mulberry (morus alba) extract oil versus placebo as a topical treatment for melasma: A randomized, single-blind, placebo-controlled trial. J. Drugs Dermatol., 2011, 10(9), 1025-1031.
[80]
Kim, Y.C.; Choi, S.Y.; Park, E.Y. Anti-melanogenic effects of black, green, and white tea extracts on immortalized melanocytes. J. Vet. Sci., 2015, 16(2), 135-143.
[http://dx.doi.org/10.4142/jvs.2015.16.2.135] [PMID: 25643794]
[81]
Tao, K.; Guo, L.; Hu, X.; Fitzgerald, C.; Rouzard, K.; Healy, J.; Tamura, M.; Stock, J.B.; Stock, M.; Pérez, E.; Fernández, J.R. Encapsulated activated grape seed extract: A novel formulation with anti-aging, skin-brightening, and hydration properties. Cosmetics, 2021, 9(1), 4.
[http://dx.doi.org/10.3390/cosmetics9010004]
[82]
Chiu, C.C.; Hsiao, Y.W.; Wen, Y.C.; Chang, T.Y.; Chen, S.H.; Jaing, T.H. Aloe vera gel for prevention of chemotherapy-induced hyperpigmentation: Four case reports. Medicine , 2023, 102(25), e34037.
[http://dx.doi.org/10.1097/MD.0000000000034037] [PMID: 37352058]
[83]
Natarelli, N.; Gahoonia, N.; Maloh, J.; Sivamani, R.K. Clinical efficacy of topical or oral soy supplementation in dermatology: A systematic review. J. Clin. Med., 2023, 12(12), 4171.
[http://dx.doi.org/10.3390/jcm12124171] [PMID: 37373864]
[84]
Solano, F.; Briganti, S.; Picardo, M.; Ghanem, G. Hypopigmenting agents: An updated review on biological, chemical and clinical aspects. Pigment Cell Res., 2006, 19(6), 550-571.
[http://dx.doi.org/10.1111/j.1600-0749.2006.00334.x] [PMID: 17083484]
[85]
Baarathi, A; Subash, VB; Bose, C; Veerichetty, V Anti tyrosinase activity of astaxanthin cream formulation for hyper pigmentation. IJPRA, 1721, 8.
[http://dx.doi.org/10.35629/7781-080217211725]
[86]
Kasanah, N.; Ulfah, M.; Imania, O.; Hanifah, A.N.; Marjan, M.I.D. Rhodophyta as potential sources of photoprotectants, antiphotoaging compounds, and hydrogels for cosmeceutical application. Molecules, 2022, 27(22), 7788.
[http://dx.doi.org/10.3390/molecules27227788] [PMID: 36431889]
[87]
David, S.R.; Baharulnizam, N.B.; Rajabalaya, R. A review on biological assays of red algae marine compounds: An insight into skin whitening activities. J. Herb. Med., 2022, 35, 100585.
[http://dx.doi.org/10.1016/j.hermed.2022.100585]
[88]
Dolorosa, M.T. Tyrosinase inhibitory activity of Sargassum plagyophyllum and Eucheuma cottonii methanol extracts. IOP Conf Ser Earth Environ Sci., 2019, 278, 012020.
[http://dx.doi.org/10.1088/1755-1315/278/1/012020]
[89]
Chan, Y.Y.; Kim, K.H.; Cheah, S.H. Inhibitory effects of Sargassum polycystum on tyrosinase activity and melanin formation in B16F10 murine melanoma cells. J. Ethnopharmacol., 2011, 137(3), 1183-1188.
[http://dx.doi.org/10.1016/j.jep.2011.07.050] [PMID: 21810462]
[90]
Shimoda, H.; Tanaka, J.; Shan, S.J.; Maoka, T. Anti-pigmentary activity of fucoxanthin and its influence on skin mRNA expression of melanogenic molecules. J. Pharm. Pharmacol., 2010, 62(9), 1137-1145.
[http://dx.doi.org/10.1111/j.2042-7158.2010.01139.x] [PMID: 20796192]
[91]
Kang, H.S.; Kim, H.R.; Byun, D.S.; Son, B.W.; Nam, T.J.; Choi, J.S. Tyrosinase inhibitors isolated from the edible brown algaEcklonia stolonifera. Arch. Pharm. Res., 2004, 27(12), 1226-1232.
[http://dx.doi.org/10.1007/BF02975886] [PMID: 15646796]
[92]
Kanlayavattanakul, M.; Lourith, N. Skin hyperpigmentation treatment using herbs: A review of clinical evidences. J. Cosmet. Laser Ther., 2018, 20(2), 123-131.
[http://dx.doi.org/10.1080/14764172.2017.1368666] [PMID: 28853960]
[93]
Makhamrueang, N.; Raiwa, A.; Jiaranaikulwanitch, J.; Kaewarsar, E.; Butrungrod, W.; Sirilun, S. Beneficial bio-extract of camellia sinensis var. assamica fermented with a combination of probiotics as a potential ingredient for skin care. Cosmetics, 2023, 10(3), 85.
[http://dx.doi.org/10.3390/cosmetics10030085]
[94]
Panichakul, T.; Rodboon, T.; Suwannalert, P.; Tripetch, C.; Rungruang, R.; Boohuad, N.; Youdee, P. Additive effect of a combination of artocarpus lakoocha and glycyrrhiza glabra extracts on tyrosinase inhibition in melanoma B16 cells. Pharmaceuticals, 2020, 13(10), 310.
[http://dx.doi.org/10.3390/ph13100310] [PMID: 33066628]
[95]
Jeon, G.; Ro, H.S.; Kim, G.R.; Lee, H.Y. Enhancement of melanogenic inhibitory effects of the leaf skin extracts of aloe barbadensis miller by the fermentation process. Fermentation , 2022, 8(11), 580.
[http://dx.doi.org/10.3390/fermentation8110580]
[96]
Lee, Y.; Kumar, S.; Kim, S.H.; Seong, K.Y.; Lee, H.; Kim, C.; Jung, Y.S.; Yang, S.Y. Odorless glutathione microneedle patches for skin whitening. Pharmaceutics, 2020, 12(2), 100.
[http://dx.doi.org/10.3390/pharmaceutics12020100] [PMID: 32012667]
[97]
Ledwoń, P.; Goldeman, W.; Hałdys, K.; Jewgiński, M.; Calamai, G.; Rossowska, J.; Papini, A.M.; Rovero, P.; Latajka, R. Tripeptides conjugated with thiosemicarbazones: New inhibitors of tyrosinase for cosmeceutical use. J. Enzyme Inhib. Med. Chem., 2023, 38(1), 2193676.
[http://dx.doi.org/10.1080/14756366.2023.2193676] [PMID: 37146256]
[98]
Castejón, N.; Thorarinsdottir, K.A.; Einarsdóttir, R.; Kristbergsson, K.; Marteinsdóttir, G. Exploring the potential of icelandic seaweeds extracts produced by aqueous pulsed electric fields-assisted extraction for cosmetic applications. Mar. Drugs, 2021, 19(12), 662.
[http://dx.doi.org/10.3390/md19120662] [PMID: 34940661]
[99]
Uchida, Y.; Kaneda, T.; Ono, M.; Matsuoka, M.; Nakamura, U.; Ishida, A.; Yamasaki, Y.; Takeo, H.; Sakurai, T. The effect of cysteine peptide ingestion on skin brightness, a randomized, double-blind, placebo-controlled, parallel-group human clinical trial. Cosmetics, 2023, 10(3), 72.
[http://dx.doi.org/10.3390/cosmetics10030072]
[100]
Tang, Q.; Yang, H.; Liu, X.; Zou, Y.; Lv, X.; Chen, K. Efficacy and safety of oral herbal drugs used as adjunctive therapy for melasma: A systematic review and meta-analysis of randomised controlled trials. Evid. Based Complement. Alternat. Med., 2021, 2021, 1-10.
[http://dx.doi.org/10.1155/2021/9628319] [PMID: 34912468]
[101]
Goodarzi, A.; Roohaninasab, M.; Mojtabaee, M.; Livani, F.; Heidari, N.; Alizadeh, N.; Khosravi, S. Beneficial esthetic lightening effects of Cuscuta extract on skin darkness in healthy individuals: A clinical trial study. J. Family Med. Prim. Care, 2022, 11(11), 6890-6895.
[http://dx.doi.org/10.4103/jfmpc.jfmpc_783_22] [PMID: 36993036]
[102]
Desai, S.; Ayres, E.; Bak, H.; Manco, M.; Lynch, S.; Raab, S.; Du, A.; Green, D.; Skobowiat, C.; Wangari-Talbot, J.; Zheng, Q. Effect of a tranexamic acid, kojic acid, and niacinamide containing serum on facial dyschromia: A clinical evaluation. J. Drugs Dermatol., 2019, 18(5), 454-459.
[PMID: 31141852]
[103]
Houshmand, E.B. Effect of glycolic acid, phytic acid, soothing complex containing emulsion on hyperpigmentation and skin luminosity: A clinical evaluation. J. Cosmet. Dermatol., 2021, 20(3), 776-780.
[http://dx.doi.org/10.1111/jocd.13950] [PMID: 33458927]
[104]
Composition for skin-whitening comprising nanoparticle of callus derived from resveratrol-enriched rice K.R. Patent 20180065998A,
[105]
A kind of facial mask. C.N. Patent 108685829A ,
[106]
A kind of method that yak milk extract prepares facial mask C.N. Patent 110075057A,
[107]
Topical skin compositions and uses thereof. C.N. Patent 108403521B,
[108]
Kaul, S.; Gulati, N.; Verma, D.; Mukherjee, S.; Nagaich, U. Role of nanotechnology in cosmeceuticals: A review of recent advances. J. Pharm. , 2018, 2018, 1-19.
[http://dx.doi.org/10.1155/2018/3420204] [PMID: 29785318]
[109]
Nanotechnology and cosmeceuticals: The good, the bad and the dangerous Available from: https://www.dermatologytimes.com/view/nanotechnology-and-cosmeceuticals-good-bad-and-dangerous (accessed April 12, 2024).
[110]
Patra, J.K.; Das, G.; Fraceto, L.F.; Campos, E.V.R.; Rodriguez-Torres, M.P.; Acosta-Torres, L.S.; Diaz-Torres, L.A.; Grillo, R.; Swamy, M.K.; Sharma, S.; Habtemariam, S.; Shin, H.S. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnology, 2018, 16(1), 71.
[http://dx.doi.org/10.1186/s12951-018-0392-8] [PMID: 30231877]
[111]
Paliwal, R.; Babu, R.J.; Palakurthi, S. Nanomedicine scale-up technologies: Feasibilities and challenges. AAPS PharmSciTech, 2014, 15(6), 1527-1534.
[http://dx.doi.org/10.1208/s12249-014-0177-9] [PMID: 25047256]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy